Reviewed by the PeptideMind Team · Updated July 15, 2026

Orforglipron Dosage Guide, Benefits & Side Effects

Approved Orforglipron delivers GLP-1 agonism in a once-daily pill, cutting body weight and HbA1c without food or water restrictions.

Chemical Makeup

35

Amino Acids

Orforglipron

Asn

N

Position 1

Pyl

O

Position 2

Thr

T

Position 3

Ala

A

Position 4

Pro

P

Position 5

Pro

P

Position 6

Leu

L

Position 7

Ile

I

Position 8

Cys

C

Position 9

Ala

A

Position 10

Asx

B

Position 11

Leu

L

Position 12

Glu

E

Position 13

Ser

S

Position 14

Tyr

Y

Position 15

Asn

N

Position 16

Thr

T

Position 17

His

H

Position 18

Glu

E

Position 19

Thr

T

Position 20

Ile

I

Position 21

Cys

C

Position 22

Ser

S

Position 23

Met

M

Position 24

Ala

A

Position 25

Leu

L

Position 26

Leu

L

Position 27

Met

M

Position 28

Pyl

O

Position 29

Leu

L

Position 30

Glu

E

Position 31

Cys

C

Position 32

Sec

U

Position 33

Leu

L

Position 34

Glu

E

Position 35

Amino acid sequence
AsparaginePosition 1
PyrrolysinePosition 2
ThreoninePosition 3
AlaninePosition 4
ProlinePosition 5
ProlinePosition 6
LeucinePosition 7
IsoleucinePosition 8
CysteinePosition 9
AlaninePosition 10
Aspartic acid or AsparaginePosition 11
LeucinePosition 12
Glutamic acidPosition 13
SerinePosition 14
TyrosinePosition 15
AsparaginePosition 16
ThreoninePosition 17
HistidinePosition 18
Glutamic acidPosition 19
ThreoninePosition 20
IsoleucinePosition 21
CysteinePosition 22
SerinePosition 23
MethioninePosition 24
AlaninePosition 25
LeucinePosition 26
LeucinePosition 27
MethioninePosition 28
PyrrolysinePosition 29
LeucinePosition 30
Glutamic acidPosition 31
CysteinePosition 32
SelenocysteinePosition 33
LeucinePosition 34
Glutamic acidPosition 35

As seen on

American PressStreet InsiderBusiness InsiderBenzingaCBSYahoo Finance

Orforglipron Dosage Guide for Weight Loss

Orforglipron is a once-daily pill version of a GLP-1 weight-loss medicine, taken by mouth instead of injected. People use it to help reduce appetite and support meaningful weight loss, with doses started low and slowly raised over time to limit stomach side effects. Oral capsule, no reconstitution needed.

Vial size

Not applicable — sold as oral capsules (commonly 6 mg)

Bacteriostatic water

N/A

Dosing

~1-3 mg, titrated up to 6-36 mg

Frequency

Daily

Cycle

Ongoing, with dose increases every 4 weeks during a multi-month titration period

Benefit

Weight Loss

Explore calculators

What is Orforglipron?

Orforglipron is an FDA-approved weight-loss medication that, unlike most drugs in its category, comes as a once-daily pill instead of an injection, and you don't need to take it with food or water restrictions. It works by reducing appetite through the same pathway as popular injectable weight-loss drugs. In clinical trials, it led to over an 11% average body weight reduction, along with improvements in blood pressure, cholesterol, and blood sugar.

Weight

Research targets include appetite regulation, fat metabolism, and body composition.

Metabolic

Research targets include glucose regulation, insulin sensitivity, and energy metabolism.

Weight

orf

Metabolic

Is Orforglipron FDA approved?

Orforglipron is FDA approved.

FDA Approved

Orforglipron has been reviewed and approved by the FDA for safety and efficacy in its approved indications.

Regulated Manufacturing

Manufactured under FDA-regulated quality standards, ensuring consistent purity and dosing.

Prescription Use

Legally available by prescription for its approved medical indications.

A smartphone screen displaying an app interface labeled "FDA Status," confirming a drug's approval status with a green "Yes" indicator. Below, there is an "Approved Use" section highlighting FDA approval, accompanied by usage instructions and additional information about the importance of regulatory approval for drug safety and effectiveness.

Our top-rated vendor

View all

Our rankings are based solely on third-party lab testing rigor, COA transparency, and pricing — no paid placements, no affiliate influence. We update this list as new data comes in.

Based on current scores, this vendor ranks highest across those criteria.

Protide Health logo

Protide Health

#1 Rated Research Peptide Supplier

How Does Orforglipron Work?

It attaches to and switches on the same appetite- and blood-sugar-regulating receptor that natural GLP-1 hormone uses, encouraging the pancreas to release insulin when blood sugar is high, slowing digestion, and reducing hunger signals in the brain. It's designed to activate this receptor in a way that may keep it working longer than the natural hormone typically does.

Activates the GLP-1 receptor

Attaches to the same appetite- and blood-sugar receptor as natural GLP-1.

Regulates blood sugar

Encourages insulin release when blood sugar is high and slows digestion.

Reduces hunger

Lowers hunger signals in the brain, with effects designed to last longer.

Orforglipron Targeted areas

How to Store Orforglipron

This one comes as an oral tablet, so no mixing is needed — just keep it at room temperature in its original packaging, away from moisture and light. A research-grade powder version should be kept cool for short-term use or frozen for the long term.

Oral Tablet Storage

No reconstitution required; store at room temperature (20–25°C).

Packaging Notes

Keep in original bottle and carton, protected from moisture and light.

Research-Grade Powder

0–4°C short-term, -20°C long-term.

A smartphone displaying a "Storage Guide" for peptides, indicating a safe storage temperature range of 2–8°C, with warnings to keep away from light, heat, and freezing. The background is light blue, and additional tips on protecting the peptides are visible below the temperature range.

What Are the Benefits of Orforglipron?

What research says it may help with, and how it works in the body.

weight loss

In the ATTAIN-2 trial, average weight loss was 10.5%, and almost 73% of people lost at least 5% of their body weight.

Led to improvements in waist size, blood pressure (down 8-12 points), and blood fat levels called triglycerides (down 20-30%).

91% of people reached near-normal blood sugar levels, compared to only 42% of those given a placebo (an inactive treatment used for comparison).

In the ATTAIN-1 trial, the 36mg dose led to an average weight loss of 12.4% (about 27 pounds) over 72 weeks, with almost 60% of people losing at least 10% of their body weight.

type 2 diabetes

Meaningfully improved how well the body responds to insulin within just 4 weeks of starting treatment.

In the ACHIEVE-1 late-stage trial, long-term blood sugar levels (measured by a marker called HbA1c) dropped 1.3-1.6 percentage points from a starting point of 8.0%, and over 76% of people reached a healthy target below 7%.

What Are the Side Effects of Orforglipron?

Who should avoid it, warning signs to watch for, and what to know before combining it with other compounds.

Who Should Avoid It

Personal or family history of medullary thyroid carcinoma

Multiple Endocrine Neoplasia syndrome type 2 (MEN2)

Pregnancy and breastfeeding

Stop Right Away If You Notice

Severe or persistent abdominal pain radiating to back (potential pancreatitis)

Neck lumps, hoarseness, difficulty swallowing, or neck swelling

Severe nausea/vomiting preventing adequate nutrition or hydration

Signs of severe hypoglycemia (confusion, sweating, rapid heartbeat)

Suicidal thoughts, severe depression, or significant mood changes

Vision changes or persistent eye pain

Milder Signs to Watch For

Discolored, crumbling, or damaged tablets indicate improper storageMoisture exposure or humidity damage
Was it helpful?Yes
No

How Long Should a Orforglipron Cycle Last?

This breaks down how long a typical Orforglipron cycle runs and what research suggests happens at each stage. Research shows that staying on a peptide continuously, without a break, may make it less effective over time.

That's why most research protocols build in a break between cycles, often called a washout period, to let the body reset before starting again.

Week 1-2
Appetite reduction typically within 1-3 days; mild to moderate nausea common
Week 2-4
Gradual weight loss begins (0.5-2 lbs per week); improved blood sugar control
Week 4-12
Reduced food cravings; GI adverse effects generally diminish; metabolic markers improving
Week 12-36
Continued progressive weight loss without plateau
Week 0-0
Long-term therapy well-tolerated; sustained benefits at 72 weeks

Orforglipron Research References

It is a fda approved compound

4Research references

Orforglipron

Orforglipron is a fda approved compound

ATTAIN-2 Phase 3 Trial (Obesity + Type 2 Diabetes)

1,613 adults; 72 weeks. 36mg dose achieved 10.5% weight loss with 72.8% achieving ≥5% weight loss.

2025

ACHIEVE-1 Phase 3 Trial (Type 2 Diabetes)

559 adults; 40 weeks. All doses significantly reduced HbA1c by 1.3-1.6%; 76.2% achieved HbA1c <7%.

2025

Phase 2 Obesity Study

272 adults; 36 weeks. Achieved up to 14.7% mean weight reduction at 36 weeks with 45mg dose.

2023

ATTAIN-1 Phase 3 Trial (Obesity)

3,127 adults; 72 weeks. 36mg dose achieved 12.4% weight loss (27.3 lbs) versus 2.1% placebo. First oral small-molecule GLP-1 completing Phase 3.

2025

Frequently Asked Questions About Orforglipron

Straight answers on reconstitution, dosing, and safety, everything you need to research with confidence. For research reference only.